Human VSIR/VISTA HEK293T Stable Cell Line

Introduction

The Human VSIR/VISTA HEK293T Stable Cell Line is a valuable tool for studying the structure, activity, and potential therapeutic applications of the VSIR/VISTA protein. This stable cell line is derived from Human embryonic kidney (HEK) 293T cells and has been genetically modified to express high levels of the VSIR/VISTA protein. In this article, we will explore the characteristics of this cell line and its potential uses in research.

Structure of VSIR/VISTA protein

VSIR/VISTA (V-domain Ig suppressor of T cell activation) is a transmembrane protein that belongs to the B7 family of immune checkpoint regulators. It is composed of an extracellular IgV-like domain, a transmembrane domain, and a short cytoplasmic tail. The extracellular domain of VSIR/VISTA is responsible for binding to its ligand, which is currently unknown. This interaction can lead to the inhibition of T cell activation, making VSIR/VISTA a potential target for cancer immunotherapy.

Activity of VSIR/VISTA protein

The exact mechanism of action of VSIR/VISTA is still being studied, but it is known to play a role in regulating T cell function. It has been shown to inhibit T cell proliferation and cytokine production, as well as promote the development of regulatory T cells. This suggests that VSIR/VISTA may have a role in maintaining immune homeostasis and preventing excessive immune responses. Additionally, VSIR/VISTA has been found to be expressed on various types of cancer cells, indicating a potential role in tumor immune evasion.

Application in flow cytometry

Flow cytometry is a powerful technique for analyzing the expression of cell surface proteins. The Human VSIR/VISTA HEK293T Stable Cell Line is a valuable tool for flow cytometry studies, as it allows for the detection of VSIR/VISTA expression on the surface of cells. This can be useful in determining the expression levels of VSIR/VISTA in different cell types and under different conditions. Furthermore, the stable expression of VSIR/VISTA in this cell line ensures consistent and reliable results in flow cytometry experiments.

Potential therapeutic target

The potential of VSIR/VISTA as a therapeutic target has garnered much attention in recent years. Its role in regulating T cell function and its expression on cancer cells make it an attractive target for cancer immunotherapy. Preclinical studies have shown promising results, with the blockade of VSIR/VISTA leading to enhanced anti-tumor immune responses and tumor regression. The Human VSIR/VISTA HEK293T Stable Cell Line can be used to further investigate the potential of VSIR/VISTA as a therapeutic target and aid in the development of novel immunotherapies.

Conclusion

In summary, the Human VSIR/VISTA HEK293T Stable Cell Line is a valuable tool for studying the structure, activity, and potential therapeutic applications of the VSIR/VISTA protein. Its stable expression of VSIR/VISTA allows for reliable and consistent results in experiments, particularly in flow cytometry studies. Furthermore, this cell line can aid in the development of novel cancer immunotherapies by providing a platform for investigating the potential of VSIR/VISTA as a therapeutic target.